Higher 362,00 €	Lower 358,00 €
Open 361,00 €	Previous close 359,50 €
Volume3 094	Traded value 1 112 763,50 €
Capitalisation / nb of shares 3 016 442 270 € / 8 390 660	Capital turnover 0,04 %
Sector Industrie Pharmaceutique et Biotechnologie	main indices SBF 120, CAC ALL-TRADABLE
Market Euronext PARIS	Eligible (France): PEA SRD

Annonce

Stock price movement

16/02/2026 à 17:35:26

Technical analysis VIRBAC

50-day moving average354,7 €	Pivot 358,17 €
Support 348,00 € -3.20 %	Résistance 368,50 € +2.50 %
1-month volatility 7,97 %	Annualized volatility 26,91 %
RSI (14d)Neutral (46)	Stochastic signal (14d) Neutre
ATR (14d)High volatility (3,36)	CMF (21d)Slightly bullish (0,10)
Bollinger (20d)Neutral	OBV (21d) OBV data unavailable

Performance history

Since January 1st, the share price of VIRBAC has risen by 0,56%. Over three years, the stock has gained 19,44%. Over the past 12 months, VIRBAC has recorded an increase of 0.56%. In the medium term, the stock has shown a rise of 0.56% over the last three months. The share has been slightly volatile over the past rolling quarter. Considering the same periods, VIRBAC has fluctuated by as much as % over the last three months and % over the past twelve months.

Please note: these indicators are for informational purposes only and do not guarantee future results. Past performance is not indicative of future performance.

Share price performance of VIRBAC over various periods:

	Perf	Higher	Lower
1 week	+2,57%	362,00	347,00
1 month	-0,139%	371,50	342,00
3 months	+1,99%	371,50	335,50
6 months	+8,61%	371,50	296,00
12 months	+13,95%	371,50	249,70
3 years	+19,44%	400,00	232,50
5 years	+59,78%	448,50	200,50
Since IPO	+2 238,00%	448,50	11,38

The information provided in this document is for informational purposes only and should not be considered investment advice. Past performance is no guarantee of future returns. This product carries a risk of capital loss.

Relatited articles about VIRBAC

News

28/01	Virbac Shares Decline at Close Despite Upward Revisions
20/01	Virbac Reports 7.9% Organic Growth in 2025
20/01	Virbac Shares Jump 5% at Close Following Strong 2025 Results
18/12	Virbac Shares Dip 2% at Midday Following Profit-Taking
07/11	VIRBAC Stock Rises +2.07% at Friday's Close
21/10	Virbac Stock: New Midday Increase of 2.64% Following Annual Target Upgrades
20/10	VIRBAC Stock: Up 2.4% at Close, Shares Break Through Resistance After Strong Quarterly Results
17/10	Virbac's Stock Soars 8.68% After Raising Annual Forecasts
17/10	Virbac Stock: Surge of 7.23% Following Annual Forecast Upgrade
14/10	Virbac Stock: 2.52% Decline in a Market Weakened by Trade Tensions
14/10	Virbac Stock Drops 2.23%, Moves Away from Its Moving Averages

Industry data

Sector	CAC40 performance (%)	Euronext performance (%)

Health Care	-2.79%	-1.74%

Pharmaceuticals & Biotechnology	-0.32%	-0.34%

Pharmaceuticals	-0.32%	-0.08%

Indice	Pts	Performance (%)

SBF 120	6296.04	+0.05%

SBF 120 data

Name	Price (€)	Perf.(%)
Best-performing stocks
Least-performing stocks

WARNINGS: The information presented here is based on data published by third-party information providers. It is not contractual and carries no guarantee of accuracy. It should not be considered as investment advice. Ideal-investisseur.fr cannot be held responsible for any potential damages or losses arising from the use of this information.

Stock VIRBAC FR0000031577

Stock data: VIRBAC